Product Information
CYCLOBENZAPRINE 5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0211 per EA under NDC 00093342001. Its NADAC has been published 247 times since Oct 6, 2021.
The High Outlier badge above means this manufacturer's average price in the Cyclobenzaprine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093342001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA071611On Market Since
7/20/2021
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 5 MG TABLET has been published 247 times since Oct 6, 2021, and over the history we have for it it has declined 35.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0211 per EA |
|---|---|
| All-time high | $0.0327 (Oct 13, 2021) |
| All-time low | $0.0157 (Nov 20, 2024) |
| 52-week high | $0.0220 |
| 52-week low | $0.0209 |
| Median price | $0.0225 |
| Average price | $0.0232 |
| Largest weekly change | +36.3% (Aug 21, 2024) |
| Weeks tracked | 247 |
| Tracking since | Oct 6, 2021 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0211 per EA (NDC 00093342001), effective Jun 24, 2026.
How has the price of CYCLOBENZAPRINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has declined 35.4%. It has been tracked across 247 weekly CMS publications since Oct 6, 2021.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 5 MG TABLET?
Since Oct 6, 2021, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has ranged from a low of $0.0157 (Nov 20, 2024) to a high of $0.0327 (Oct 13, 2021), with a median of $0.0225 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 5 MG TABLET?
8 NADAC-published products share the same active ingredient, strength, and dosage form as CYCLOBENZAPRINE 5 MG TABLET, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 5 MG TABLET?
CYCLOBENZAPRINE 5 MG TABLET (NDC 00093342001) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification